 SAN DIEGO, June 24, 2021 PRNewswire -- Aethlon Medical, Inc. Nasdaq: AEMD, a medical technology company focused on developing products to diagnose and treat life and organ threatening diseases, today reported financial results for its fiscal year ended March 31, 2021 and provided an update on recent developments. Company Updates SARS-CoV-2COVID-19 SARS-COV-2, the causative agent of COVID-19, is a member of the coronavirus family, which includes the original SARS virus, SARS-CoV, and the MERS virus. 